Fonke Chiropractic and Decompression Center

11/03/2025

🎉Thank you to everyone who donated last week! We overflowed the mini van. 🎉

10/29/2025

👻Patient appreciation week has come to a close. Thank you to everyone who participated! We had a blast! 🎃Happy Halloween!🎃

10/28/2025

👻 We are starting to line the halls with donations on day 2 of patient appreciation week. Thank you to all who have donated!

10/27/2025

👻Our patient appreciation week has started! A big thank you to everyone who has already donated.🎃
It's not too late! We still have some availibility Wednesday morning.

10/01/2025

We are excited and ready for another appreciation week! We hope to see you there!

09/16/2025

Fonke Family of 5 💕

08/01/2025

After a very long 21 days in the NICU, Hannah and Amelia are back together again at HOME!!

07/23/2025

Interesting study…

A drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.

A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI).

Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade.

The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.

Gabapentin, marketed under names like Neurontin, has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline.

While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.

Source: Regional Anesthesia & Pain Medicine (2025).